Full Text
Reimbursement Recommendations Based on Phase II Clinical Evidence for Oncology Drugs in Canada

Abstract

Authors

RB Milenkovski S Yunger D Shum

Back to Volume 19, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×